Canadian firm Valeant Pharmaceuticals International, has named Ari Kellen as Executive Vice President/Company Group Chairman, effective 1 January, 2014.
Kellen was a senior partner in McKinsey & Company's Mid-Atlantic Office. Since joining McKinsey in March 1991, he has led numerous strategy, organisation and performance improvement studies for healthcare companies, including corporate strategies for boards and top management teams, business unit strategies for medical device, pharmaceutical and biotechnology, and healthcare services clients, and regional and country growth strategies.
